Cardiovascular and VTE Risk w/JAKi Treatment of Skin Disorders A JAMA systematic review and meta-analysis has shown the use of JAKi in immune-mediated inflammatory skin diseases was not associated w/ increased risk of all-cause mortality, MACE, or VTE. https://t.co/XYAeLnFvHr https://t.co/tGRNEUEZj9